Adam Keeney insider trades
Open-market stock purchases and sales by Adam Keeney, Head of Corporate Development at Biogen Inc, from SEC Form 4 filings since May 1, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 1, 2026 | BIIB Biogen Inc | Sold (not open market) | $85.1K |
| May 1, 2026 | BIIB Biogen Inc | Bought (not open market) | — |
| Feb 13, 2026 | BIIB Biogen Inc | Bought (not open market) | — |
| Feb 6, 2026 | BIIB Biogen Inc | Sold (not open market) | $118K |
| Feb 6, 2026 | BIIB Biogen Inc | Sold (not open market) | $200K |
| Feb 6, 2026 | BIIB Biogen Inc | Bought (not open market) | — |
| Feb 6, 2026 | BIIB Biogen Inc | Bought (not open market) | — |
Companies traded
- BIIB Biogen Inc: other filings, last May 1, 2026